Inside the battle over COVID vaccine intellectual property rights
•May 6, 2021
The German pharmaceutical company that developed a COVID-19 vaccine along with Pfizer has hit out at a proposal to suspend intell
•May 6, 2021
The German pharmaceutical company that developed a COVID-19 vaccine along with Pfizer has hit out at a proposal to suspend intellectual property rights.
BioNTech says patents are not the limiting factor for the production or supply of its vaccine, and would not boost stocks around the world anytime soon.
There is a renewed push to suspend patents backed by the US president.
India and South Africa have been leading the campaign at the World Trade Organization, calling for the waiver.
But the European Union is yet to do the same.
Al Jazeera's Elizabeth Puranam reports from New Delhi, India.
Chile uses copper to fight coronavirus...
EU sets coronavirus vaccine export controls...
10193 
